DE69929616D1 - Oxyhuminsäure und ihre verwendung zur behandlung von verschiedenenen störungen - Google Patents

Oxyhuminsäure und ihre verwendung zur behandlung von verschiedenenen störungen

Info

Publication number
DE69929616D1
DE69929616D1 DE69929616T DE69929616T DE69929616D1 DE 69929616 D1 DE69929616 D1 DE 69929616D1 DE 69929616 T DE69929616 T DE 69929616T DE 69929616 T DE69929616 T DE 69929616T DE 69929616 D1 DE69929616 D1 DE 69929616D1
Authority
DE
Germany
Prior art keywords
acid
oxyhumic
treatment
different disorder
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69929616T
Other languages
English (en)
Other versions
DE69929616T2 (de
Inventor
Johannes Dekker
Constance Elizabeth Medlen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfeinsmith Ltd
Original Assignee
Pfeinsmith Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfeinsmith Ltd filed Critical Pfeinsmith Ltd
Application granted granted Critical
Publication of DE69929616D1 publication Critical patent/DE69929616D1/de
Publication of DE69929616T2 publication Critical patent/DE69929616T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A61K35/10—Peat; Amber; Turf; Humus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Fertilizers (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69929616T 1998-09-23 1999-09-22 Oxyhuminsäure und ihre verwendung zur behandlung von verschiedenenen störungen Expired - Lifetime DE69929616T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
ZA988731 1998-09-23
ZA9808731 1998-09-23
ZA991926 1999-03-10
ZA9901926 1999-03-10
PCT/IB1999/001569 WO2000016786A2 (en) 1998-09-23 1999-09-22 Oxihumic acid and its use in the treatment of various conditions

Publications (2)

Publication Number Publication Date
DE69929616D1 true DE69929616D1 (de) 2006-04-13
DE69929616T2 DE69929616T2 (de) 2006-07-27

Family

ID=27144962

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69929616T Expired - Lifetime DE69929616T2 (de) 1998-09-23 1999-09-22 Oxyhuminsäure und ihre verwendung zur behandlung von verschiedenenen störungen

Country Status (6)

Country Link
US (1) US6630179B1 (de)
EP (1) EP1115408B1 (de)
AT (1) ATE316379T1 (de)
AU (2) AU5643299A (de)
DE (1) DE69929616T2 (de)
WO (2) WO2000016785A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2178702C1 (ru) * 2001-02-21 2002-01-27 Общество с ограниченной ответственностью "Нобель" Антираковое средство
US20070212434A1 (en) * 2006-03-07 2007-09-13 Day Kenneth S Compositions and methods for human use containing fulvic acid
ES2399993T3 (es) 2007-03-02 2013-04-04 Protectimmun Gmbh Composición farmacéutica para la protección frente a alergias y enfermedades inflamatorias
WO2010020379A1 (en) * 2008-08-16 2010-02-25 Protectimmun Gmbh Composition for prevention and treatment of allergic and/or inflammatory diseases
RU2531945C2 (ru) * 2013-01-25 2014-10-27 Федеральное государственное бюджетное учреждение "Государственный научный центр "Институт иммунологии" Федерального медико-биологического агентства Средство против передачи вич/спид половым путем
EP2878342A1 (de) 2013-11-27 2015-06-03 Latvijas Universitate Verfahren zur Extraktion von Torfwirkstoffen und Verwendung von deren Kombination in hautregenerierenden kosmetischen Formulierungen
RU2624851C1 (ru) * 2016-04-18 2017-07-07 Елена Николаевна Зайцева Средство, обладающее мочегонной активностью
RU2678986C1 (ru) * 2018-03-23 2019-02-05 Федеральное бюджетное учреждение науки "Государственный научный центр вирусологии и биотехнологии "Вектор" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека (ФБУН ГНЦ ВБ "Вектор" Роспотребнадзора) Противовирусное средство на основе гуминовых кислот
CN109504713B (zh) * 2018-12-04 2022-05-17 齐鲁工业大学 利用拜氏梭菌制备高酯键腐植酸制剂的方法及应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ225271A (en) * 1987-07-08 1991-02-26 Nat Energy Council Oxidising coal using a gaseous oxidant
DE3903773A1 (de) * 1988-02-11 1989-09-14 Nat Energy Council Eine mischung mit bakteriozider oder bakteriostatischer aktivitaet
DE69224024T2 (de) * 1991-03-16 1998-08-27 Torf Ets Torf-derivierte bioaktive produkte und diese enthaltende pharmazeutische und kosmetische zusammensetzungen
DE539610T1 (de) * 1991-10-26 1993-12-16 Torf Ets Verfahren und Zusammensetzung zur Bestimmung der Immunologischen Aktivität von aktiven Substanzen enthaltende Lösungen.
AU7877894A (en) 1993-09-24 1995-04-10 Maurizio Zanetti Treatment of hiv infection with humic acid
ATE206163T1 (de) * 1994-04-22 2001-10-15 Corixa Corp Verbindungen und methoden für die stimulierungen und die erhöhung von schutzimmunantworten und il- 12 herstellung
US5945446A (en) * 1997-02-10 1999-08-31 Laubc Biochemicals, Corporation Process for preparing synthetic soil-extract materials and medicaments based thereon

Also Published As

Publication number Publication date
WO2000016785A2 (en) 2000-03-30
DE69929616T2 (de) 2006-07-27
WO2000016785A3 (en) 2000-05-25
AU5643299A (en) 2000-04-10
AU5643499A (en) 2000-04-10
ATE316379T1 (de) 2006-02-15
AU772123B2 (en) 2004-04-08
EP1115408A2 (de) 2001-07-18
WO2000016786A2 (en) 2000-03-30
EP1115408B1 (de) 2006-01-25
US6630179B1 (en) 2003-10-07
WO2000016786A3 (en) 2000-06-08

Similar Documents

Publication Publication Date Title
DE69915458D1 (de) Dextran formulierungen zur behandlung entzündlicher gelenkerkrankungen
ATE267798T1 (de) Kombinierte wirkstoffe als methode zur gezielten wirkstoff-freisetzung
AU8335291A (en) Drugs, their manufacture, and their use as painkillers and/or to treat inflammations in humans and animals
DE69232263D1 (de) Radikalfänger ("spin traps") zur behandlung von mit oxidation von lipiden und proteinen verbundenen erkrankungen
ATE336997T1 (de) Fulvinsäure und dessen verwendung zur behandlung von diversen krankheitszuständen
RU95101385A (ru) Продукты, содержащие g-csf и tnf связующие протеина
DE69929616D1 (de) Oxyhuminsäure und ihre verwendung zur behandlung von verschiedenenen störungen
ATE265851T1 (de) Behandlung von erkrankungen, die vom cytokinwachstumsfaktor verursacht werden
DE60018409D1 (de) Verwendung von antiseptika zur herstelllung von arzneimitteln zur prophylaxe und behandlung von infektionen und/ oder funktionellen gewebeumformungen im körperinneren
DE69833876D1 (de) Zusammensetzungen und methoden zur zielgerichteten abgabe von biologisch aktivenfaktoren
DE60043886D1 (de) Formulierungen mit povidon-iod zur behandlung von wunden
DK0588477T3 (da) Medicinsk præparat omfatende TCF-11
ATE185274T1 (de) Therapeutisches mittel gegen drohenden abortus
BG103905A (en) New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine
DE69431430T2 (de) Faktor XIII zur Behandlung von Hautwunden
ATE295159T1 (de) Bupropion zur behandlung von viralen erkrankungen
FR2786699B1 (fr) Medicament destine notamment a prevenir ou traiter les dysfonctions sexuelles
DE69932741D1 (de) Verwendung von n-glycolneuraminsäure und deren derivaten zur herstellung eines medikaments zur behandlung von hiv-infektionen
DE69330809D1 (de) Therapeutisches Agens für Neutropenie
SU1629062A1 (ru) Способ лечени колибактериоза тел т
EA200000011A1 (ru) Средства и способы доставки лекарственных препаратов для терапии вирусных и бактериальных инфекций и синдромов истощения
ATE218869T1 (de) Verfahren zur behandlung von lebererkrankungen und ähnlichen indikationen mit vasodilatierenden wirkstoffen
RU93052444A (ru) Лекарственный препарат бан
RU92011168A (ru) Препарат для лечения гинекологических заболеваний
RU94022334A (ru) Способ лечения и профилактики инвазионных заболеваний

Legal Events

Date Code Title Description
8364 No opposition during term of opposition